Drug Guide
Lidocaine Hydrochloride with Epinephrine
Classification
Therapeutic: Local anesthetic and vasoconstrictor
Pharmacological: Amide local anesthetic with adrenergic agent
FDA Approved Indications
- Local anesthesia for minor surgical procedures including dental, surgical, and diagnostic procedures
Mechanism of Action
Lidocaine stabilizes neuronal membranes by inhibiting the influx of sodium ions during depolarization, thereby blocking nerve impulse conduction. Epinephrine causes vasoconstriction at the site of injection, prolonging anesthesia and reducing systemic absorption.
Dosage and Administration
Adult: Dose depends on procedure; typically 1-5 mL per site, not to exceed maximum doses (e.g., 4.5 mg/kg without epinephrine, 7 mg/kg with epinephrine).
Pediatric: Dosing based on weight; consult specific guidelines.
Geriatric: Use with caution; start at lower end of dosing range.
Renal Impairment: Adjust dose as needed; monitor for toxicity.
Hepatic Impairment: Use caution; lidocaine is metabolized in the liver.
Pharmacokinetics
Absorption: Absorbed rapidly at the injection site.
Distribution: Widely distributed into body tissues; crosses placenta.
Metabolism: Hepatic metabolism via CYP1A2 and CYP3A4 enzymes.
Excretion: Renal excretion of metabolites.
Half Life: Approximately 1.5 to 2 hours in healthy adults.
Contraindications
- Hypersensitivity to lidocaine, amide-type local anesthetics, or epinephrine.
- History of severe adverse reactions to local anesthetics.
Precautions
- Use with caution in patients with cardiovascular disease, significant hypertension, or hyperthyroidism. Avoid in patients with narrow-angle glaucoma and those on monoamine oxidase inhibitors (MAOIs).
Adverse Reactions - Common
- Transient local tissue irritation or burning. (Common)
- Headache, dizziness. (Uncommon)
Adverse Reactions - Serious
- Anaphylaxis. (Rare)
- Cardiovascular effects such as arrhythmias, hypertension, or hypotension. (Uncommon)
Drug-Drug Interactions
- Other vasoconstrictors, other local anesthetics.
- Certain beta-blockers and monoamine oxidase inhibitors (MAOIs).
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Monitor for allergic reactions, cardiovascular status, and CNS effects.
Diagnoses:
- Risk for allergic reaction.
- Ineffective tissue perfusion.
Implementation: Administer slowly, aspirate before injection, and use the lowest effective dose.
Evaluation: Monitor for adequate anesthesia and absence of adverse reactions.
Patient/Family Teaching
- Report signs of allergic reactions such as rash, itching, or swelling.
- Avoid driving or operating machinery until anesthesia wears off.
- Inform about possible side effects and when to seek medical attention.
Special Considerations
Black Box Warnings:
- Epinephrine should not be used in fingers, toes, noses, ears, or appendages due to risk of ischemia.
Genetic Factors: Variability in metabolism may occur due to genetic differences in CYP enzymes.
Lab Test Interference: None significant.
Overdose Management
Signs/Symptoms: CNS excitation (tremors, seizures), cardiovascular depression, arrhythmias.
Treatment: Supportive care; administer benzodiazepines for seizures, monitored cardiac support, lipid emulsion therapy for systemic toxicity.
Storage and Handling
Storage: Store at room temperature, away from light and moisture.
Stability: Stable for expiration date on package.